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18.9) and also weakly associated with
development of bloody diarrhea (OR
= 2.5) (2). Avery uses the term endo-
geneity as it is used in econometric
analyses; however, the term “interme-
diary variable,” i.e., a factor in the
causal pathway leading from exposure
to disease, is more frequently used in
epidemiology. In this context, we
chose to consider bloody diarrhea as a
potential confounder (3). A con-
founder is a risk factor but is also inde-
pendently associated with the expo-
sure variable of interest and is not
regarded as part of the causal pathway
(see online Figure at http://www.cdc.
gov/ ncidod/EID/vol 11no03/05-0071-
G.htm). Bloody diarrhea may act as a
confounder if patients with bloody
stools are treated differently by the
examining physicians or if, for
instance, unknown virulence factors
contribute to the risk of having bloody
stools.
A second line of critique of our
methods apparently develops from the
idea that virulence factors determine
the serogroup. This idea, however, is a
biological misconception. In fact, vir-
ulence genes and serogroup are inde-
pendent at the genetic level, and an
important point of our article is that
HUS is determined by the virulence
gene composition of the strain rather
than the serogroup.
Regardless of the status of the
bloody diarrhea variable, excluding it
from the model doesn’t change the
conclusions of the article. A revised
model contains only the significant
variables age and stx2 (Table).
Serotype O157 is still not an inde-
pendent predictor of HUS, and this
result is robust. 
Steen Ethelberg* and Kåre Mølbak*
*Statens Serum Institut, Copenhagen,
Denmark
References
1. Avery G. Endogeneity in logistic regression
models. Emerg Infect Dis. 2005;11:
499–500..
2. Ethelberg S, Olsen KE, Scheutz F, Jensen
C, Schiellerup P, Enberg J, et al. Virulence
factors for hemolytic uremic syndrome,
Denmark. Emerg Infect Dis. 2004;10:
842–7.
3. Griffin PM, Mead PS, Sivapalasingam S.
Escherichia coli O157:H7 and other entero-
haemorrhagic E. coli. In: Blaser MJ, Smith
PD, Ravdin JI, Greenberg HB, Guerrant
RL, editors. Infections of the gastrointesti-
nal tract. Philadelphia: Lippincott Williams
& Wilkins; 2002. p. 627–42.
Address for correspondence: Steen Ethelberg,
Department of Bacteriology, Mycology and
Parasitology, Statens Serum Institut, Artillerivej
5, DK-2300 Copenhagen S, Denmark; fax: 45-
3268-8238; email: set@ssi.dk
Rectal
Lymphogranuloma
Venereum, France 
To the Editor: Lymphogranuloma
venereum (LGV), a sexually transmit-
ted disease (STD) caused by
Chlamydia trachomatis serovars L1,
L2, or L3, is prevalent in tropical
areas but occurs sporadically in the
western world, where most cases are
imported (1). LVG commonly causes
inflammation and swelling of the
inguinal lymph nodes, but it can also
involve the rectum and cause acute
proctitis, particularly among men who
have sex with men. However, LGV
serovars of C. trachomatis remain a
rare cause of acute proctitis, which is
most frequently caused by Neisseria
gonorrhoeae or by non-LGV C. tra-
chomatis (2). In 1981, in a group of 96
men who have sex with men with
symptoms suggestive of proctitis in
the United States, Quinn et al. found
that 3 of 14 C. trachomatis infections
were caused by LGV serovar L2 (3).
In France, 2 cases of rectal LGV were
reported in an STD clinic in Paris
from 1981 to 1986 (4). In 2003, an
outbreak of 15 rectal LGV cases was
reported among men who have sex
with men in Rotterdam; 13 were HIV-
infected, and all reported unprotected
sex in neighboring countries, includ-
ing Belgium, France, and the United
Kingdom (5). At the same time, a rise
in C. trachomatis proctitis (diagnosed
by using polymerase chain reaction
[PCR]; [Cobas Amplicor Roche
Diagnostic System, Meylan, France])
was detected in 3 laboratories in Paris
and in the C. trachomatis national ref-
erence center located in Bordeaux. To
identify the serovars of these C. tra-
chomatis spp., all stored rectal speci-
mens were analyzed by using a nested
omp1 PCR-restriction fragment
length polymorphism assay. The
amplified DNA product was digested
by restriction enzymes. Analysis of
digested DNAwas performed by elec-
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trophoresis. Patterns were compared
visually with reference patterns (6). 
From January 1, 2003, to March
31, 2004, a total of 44 of 124 male
rectal swabs were positive for C. tra-
chomatis. Of those, 38 were identified
as belonging to the L2 serotype,
which confirms the diagnosis of rectal
LGV. Epidemiologic information was
retrospectively obtained by clinicians
through review of medical records,
telephone interview, or both. A com-
plete history was available for 14 of
the 38 cases. All 14 men reported
unprotected anal sex with anonymous
male sex partners in France, and none
reported a stay in an LGV-endemic
area. Their mean age was 40 years
(31–50); 8 were HIV-infected, and 9
had another concomitant STD. The
mean duration of symptoms before
LGV diagnosis was 50 days (range
11–120 days). All 14 patients had
symptoms of acute proctitis, including
rectal pain, discharge, and tenesmus,
and 3 (all HIV-infected) had fever.
Deep, extended rectal ulcerations
were reported in 8 patients, 3 of
whom were HIV-infected and had
lesions suggestive of rectal carcino-
ma. In 1 patient in whom a late diag-
nosis was made 4 months after the
onset of symptoms, a rectal tumorlike
stricture was observed. All 14 patients
were treated with tetracycline for a
mean duration of 16 days (range
10–60 days).
An information campaign among
microbiologists and clinicians and a
sentinel LGV surveillance system
were launched in April 2004.
Subsequently, LGV was diagnosed in
65 additional male patients, some ret-
rospectively. In total, rectal LGV was
diagnosed in 103 patients from July
2002 to August 2004 (Figure).
Prompt diagnosis and treatment is
indeed paramount to prevention and
control. Diagnosis may be further
hampered because rectal LGV may
mimic other conditions such as rectal
carcinoma or Crohn disease.
Treatment duration should be no
shorter than 21 days, and follow-up
examinations should be conducted
until all signs and symptoms have
resolved (7,8). If left untreated, rectal
LGV could lead to serious complica-
tions such as rectal stricture (1). If
recently exposed to infection, sexual
contacts should receive prophylactic
treatment to prevent reinfection and to
eliminate a potential reservoir. The
emergence of rectal LGV, character-
ized by deep mucosal ulcerations and
frequently occurring in HIV-infected
men who have sex with men, is a seri-
ous concern for the gay community in
Europe. 
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Pertussis in
Soldiers, Israel
To the Editor: The role of adults
as reservoirs of pertussis was previ-
ously well established (1–7). Young
army recruits undergoing basic train-
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Figure. Number of rectal lymphogranuloma venereum cases diagnosed in men in France,
July 2002–August 2004.